UK to get 60m trial vaccines
Print Edition
Pharma giants Sanofi and GSK said yesterday they have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine.
The agreement covers a vaccine candidate developed by France鈥檚 Sanofi in partnership with the UK鈥檚 GSK and is subject to a 鈥渇inal contract.鈥
Amid the global race to find a vaccine to halt the pandemic, Sanofi announced 鈥渙ngoing discussions with the European Commission, with France and Italy on the negotiation team, and other governments to ensure global access to a novel coronavirus vaccine.鈥
Both companies voiced in a statement their commitment 鈥渢o making their COVID-19 vaccine candidate affordable and available globally.鈥
The vaccine candidate 鈥渉as the potential to play a significant role in overcoming the COVID-19 pandemic, both in the UK and around the world,鈥 said GSK Vaccines President Roger Connor.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
